Pay in 4 interest-free payments of $7.42 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
GLP-1 receptor agonists rarely cause hypoglycaemia when used alone, but the risk increases when combined with insulin or sulfonylureasyour clinician may need to reduce doses of these medications
Large real-world study examines how patients use GLP-1 medications Patients without diabetes who switched between glucagon-like peptide-1 receptor agonist (GLP-1RA) medications for overweight or obesity were more likely to remain engaged with treatment than those who stayed on the same medication, according to new research conducted by investigators at UT Southwestern Medical Center
Characteristics of cultured human melanocytes isolated from different stages of tumor progression
Despite this enthusiasm for apoptosis, there was limited concern that if this hypothesis were correct, potent pancaspase inhibitors could prevent all cell death and cure most diseases
US$ 24.17
US$ 29.58
US$ 29.36
US$ 22.71
US$ 21.97
